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Abstract
OBJECTIVES—To investigate the comparative acute health effects associated with exposures to 
diesel and 75% biodiesel/25% diesel (B75) blend fuel emissions.
METHODS—We analyzed multiple health endpoints in 48 healthy adults before and after 
exposures to diesel and B75 emissions in an underground mine setting: lung function; lung and 
systemic inflammation; novel biomarkers of exposure; and oxidative stress were assessed.
RESULTS—B75 reduced respirable diesel particulate matter (rDPM) by 20%. Lung function 
declined significantly more following exposure to diesel emissions. Lung inflammatory cells 
along with sputum and plasma inflammatory mediators increased significantly to similar levels 
with both exposures. Urinary 8-hydroxydeoxyguanosine (8-OHdG), a marker of oxidative stress, 
was not significantly changed following either exposure.
CONCLUSIONS—Use of B75 lowered rDPM exposure and some associated acute health 
effects, although lung and systemic inflammation were not reduced compared with diesel use.
Introduction
Diesel engines are widely used in on- and off-road applications including personal vehicles, 
trucks, buses, trains, ships, underground mining, construction, and agriculture. Exposure to 
diesel engine emissions is associated with chronic bronchitis, respiratory tract infections, 
asthma exacerbation, and increased cardiovascular morbidity and mortality (1–4), and in 
2012, diesel emissions were classified by the International Agency for Research on Cancer 
(IARC) as a Group 1 carcinogen in humans (5). Given the health effects of diesel emissions 
and ubiquitous environmental exposures, reducing engine emissions has become a public 
health priority.
In recent years, alternative fuels such as biodiesel have been introduced in attempts to 
reduce diesel particulate matter (DPM) emissions. Often used as a blend with diesel to 
facilitate use in current engines, biodiesel has been shown to reduce respirable particulates 
(6), dependent on fuel formulation, pollution control devices, and engine operating 
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conditions (7, 8). Despite the increasing usage of biodiesel, there is a lack of information on 
the human health effects of exposure to these emissions and recent in vitro and in vivo 
studies suggest that exposure to biodiesel particulates may be more toxic than diesel 
particulates at equivalent concentrations (9–12).
The present study was conducted to compare the acute human health effects related to 
exposures to emissions from diesel and a 75% biodiesel/25% diesel (B75) blend fuel in an 
underground mining setting, where DPM concentrations are among the highest reported 
(13). The null hypothesis was that switching to B75 would not reduce the adverse health 
effects compared with exposures to diesel emissions.
Materials and Methods
Subjects
Human subject recruitment and testing procedures were approved by the University of 
Arizona (UA) Institutional Review Board. Subjects were recruited from the UA campus. 
Inclusion criteria included being at least 18 years of age. Exclusion criteria included recent 
(within 4 days) diesel exhaust or other significant occupational inhalation exposure, 
smoking, a diagnosis of asthma, heart disease, diabetes, hypertension, renal or hepatic 
failure, a difference in blood pressure greater than 15 mmHg between the arms, baseline 
forced expiratory volume in one second (FEV1) divided by forced vital capacity (FVC) 
<0.7, or current respiratory illness.
LHD training and baseline testing
After written consent was obtained, subjects were scheduled for load-haul-dump (LHD) 
vehicle driver’s training a minimum of 96 hours prior to baseline testing, which was 
completed at least 72 hours prior to the first emissions exposure. Baseline testing consisted 
of blood pressure measurement, phlebotomy, pulmonary function testing, and sputum 
induction. Blood pressure was measured in both arms using an automated 
sphygmomanometer (OMRON, Bannockburn, IL). Blood samples were collected in serum 
clot activator, heparin, sodium citrate, and EDTA tubes. The serum tube was allowed to clot 
for 30 minutes at room temperature prior to centrifugation. All of the tubes were initially 
centrifuged at 1000 x g for 15 minutes. The heparin and sodium citrate tubes were decanted 
and a second 10-minute centrifugation step at 10,000 x g was added to obtain complete 
platelet removal. Serum and plasma were decanted and stored immediately at −80°C until 
assayed. Pulmonary function testing was performed following American Thoracic Society 
standards in a sitting position using an EasyOne spirometer (ndd Medical Technologies, 
Andover, MA). FEV1, FVC and age- and height-adjusted percent predicted values were 
recorded. A minimum of 3 trials were performed, with a maximum of 8 trials at any one 
sitting. Testing was continued until the two largest FEV1 values were within 0.150 L of each 
other, with the same process followed for FVC. Sputum induction was performed using 
DeVilbiss Ultra-Neb 99HD ultrasonic nebulizers (Somerset, PA) with 3% saline for 30 
minutes, as previously described (14). Samples were diluted with 10% Sputolysin® 
(Calbiochem, San Diego,CA) in phosphate buffered saline, and incubated at room 
temperature for 15 minutes with gentle mixing by inversion every 5 minutes. A 500 μl 
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aliquot was removed prior to centrifugation; 50 μl of sample was mixed with 50 μl Trypan 
Blue stain (Sigma Chemical Co., St. Louis, MO) prior to total cell counting performed using 
a hemocytometer. The remaining aliquot was mixed with an equal amount (450 μl) of 
preservative (Histochoice, AMRESCO, Solon, OH) and 500 μl of the mixture was 
cytocentrifuged, stained with Diff-Quik® (Dade Behring AG, Switzerland), and analyzed 
using the first 100 white cells counted, excluding epithelial cells. The remaining sample was 
centrifuged at 1900 rpm for 20 minutes and the supernatant and cell pellet were stored at 
-80°C until assayed.
Pre-exposure testing on emissions exposure day
On the emissions exposure day, subjects were instructed to fast for at least 6 hours prior to 
arriving at the UA San Xavier Mining Laboratory (SXML). First morning void urine 
samples and all subsequent voids continuing through the end of the day’s testing were 
refrigerated at 4°C until processing. Baseline exhaled carbon monoxide, expressed as 
percent carboxyhemoglobin (%COHb) and baseline fraction of exhaled nitric oxide (FENO) 
testing were performed following American Thoracic Society recommendations and 
standards, respectively; using the microCO Breath Carbon Monoxide Monitor (Micro 
Direct, Lewiston, ME), and a NIOX MINO (Aerocrine, Inc., New Providence, NH). 
Following a 20-minute rest in a supine position and ultrasound testing for brachial artery 
flow-mediated dilation (FMD, results to be reported separately) (15), subjects were supplied 
a carbohydrate meal (cereal, 2% milk, energy bars) and water.
Fuels, equipment, and study site
The fuels, equipment, and study site description have previously been reported (16). Briefly, 
ultra-low sulfur #2 diesel (Arizona Petroleum, Tucson, AZ) was used for diesel exposure 
testing and B75 was prepared by mixing the aforementioned diesel fuel at 25% by volume 
with a soy methyl ester (SME) biodiesel fuel (ASTM D6751-compliant; Arizona Petroleum, 
Tucson, AZ). Exposure to vehicle emissions was evaluated during mucking activities in the 
SXML. A 2005 Wagner B10-203 LHD vehicle with open cab and diesel oxidation catalyst 
(DOC), but no diesel particulate filter, was used for the study and operated on a 35 meter all-
underground route with a 9.5% grade. As in typical underground mining, the mucking path 
and muck pile were sprayed with water in order to limit airborne dust exposures.
Diesel and B75 emission exposures
Exposure-related health effects to diesel and B75 fuel emissions were measured under the 
same engine operating conditions. All protocols performed by the subjects during their first 
fuel appointment day at the mine were repeated using the second fuel with a minimum of 
two weeks between exposures. In 2013, the first fuel was diesel. In 2014, with one 
exception, the first fuel was B75. The fuel tanks were emptied between each fuel type and 
the LHD operated for approximately one hour with the “new” fuel to ensure all remnants of 
the previous fuel were removed. For each fuel type, two research subjects alternately 
mucked (110 minutes) and closely observed (80 minutes) LHD operation, with a 10-minute 
break during each 200-minute exposure rotation. Methods for personal integrated sample 
collection, monitoring, and analysis of particulates and gases have previously been reported 
(16).
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Post-diesel and -B75 emission exposure testing
At the end of the 200 minute exposure period, the subjects repeated the exhaled CO 
monitoring immediately upon exiting the mine. FENO measurement was repeated 
approximately 5 minutes after exiting the mine. Subjects repeated the 20-minute rest prior to 
the measurement of post-exposure FMD. The subjects were then supplied a small lunch 
consisting of a sandwich, fruit, and water; and returned to the UA campus for a blood draw 
at 2 hours after exiting the mine (5.5 hours after initial exposure). At 5 hours after exiting 
the mine (8.5 hours after initial exposure), the subjects returned again to the UA campus for 
the remainder of the biological sample testing, including blood pressure, spirometry, sputum 
induction, and urine collection, conducted in the same fashion as during baseline and/or pre-
exposure testing.
Biological assays
Urine samples were allowed to return to room temperature, mixed well, and an aliquot of 
urine was transferred to a 15ml tube, centrifuged at 1000 x g for 10 minutes, and stored at 
−80°C until assayed. Specific gravity was measured on the unspun urine (10SG Urine 
Reagent Strips, Fisherbrand, Hanover, Germany). First catch (baseline) and last catch of the 
day (generally 8–10 hours post-exposure) urine was used for 8-hydroxydeoxyguanosine (8-
OHdG) analysis. All sputum and plasma samples were allowed to thaw to room temperature, 
vortexed, and then briefly centrifuged to pellet any precipitates prior to assays. Endothelin-1 
(ET-1), soluble P-selectin, and tenascin-C (TN-C) were assayed with heparin plasma 
samples, while high sensitivity interleukin-6 (IL-6), high sensitivity interleukin-8 (IL-8), 
matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO), growth-regulated alpha 
protein (GRO-α), and matrix metalloproteinase-8 (MMP-8) were assayed with sputum 
samples, and creatinine and urinary 8-OHdG were assayed with urine samples. The level of 
each sputum analyte was adjusted to total protein for normalization. Standards, controls, and 
samples were assayed in duplicate using the enzyme-linked immunosorbent (ELISA) assay 
kits developed by R&D Systems, Inc. (Minneapolis, MN) with two exceptions: 8-OHdG 
was assayed in triplicate using the ELISA kit supplied by Japan Institute for the Control of 
Aging (Fukuroi, Japan) and TN-C high molecular weight variants were assayed in duplicate 
using the ELISA kit supplied by IBL America, Inc. (Minneapolis, MN). Absorbance for 
standards, controls, and samples were obtained using an automated microplate reader 
(Model ILx808, BioTek Instruments, Inc., Winooski, VT) and concentrations determined 
from the standard curve using a four-parameter algorithm for best fit, as determined by the 
BioTek KC4 automated software program (Winooski, VT).
LC-MS/MS analysis
See Supplemental Material for detailed methods. Sputum and plasma samples from six 
subjects (3 males and 3 females) were analyzed for potential novel biomarkers of effect 
following diesel and B75 exposure. Proteins were extracted, reduced with dithiothreitol 
(DTT), alkylated with iodoacetamide, and then digested with Lys-C/trypsin mix (Promega, 
Madison, WI) following manufacturers recommendations. The resulting peptide samples 
were desalted using solid-phase extraction (SPE), and concentrated to dryness prior to 
analysis by high resolution LC-MS/MS for protein identification using a LTQ Orbitrap 
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Velos mass spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped with an Advion 
nanomate ESI source (Advion, Ithaca, NY). Three proteins (GRO-α, MMP-8, and TN-C) 
considered prime candidate biomarkers were further validated in the entirety of the sputum 
and plasma samples using ELISA analysis.
Statistical analysis
All manual results were double entered into a spreadsheet and the results checked for 
accuracy. Industrial hygiene measurements were time-weighted over an 8-hour exposure 
period (TWA8), as previously described (16). TWA8 exposure means were first compared 
across fuel types using the Kruskal-Wallis rank test with Bonferroni correction (STATA 
12.0, StataCorp, College Station, TX). Those analytes with significant differences across 
post-diesel and post-B75 sampling were further analyzed using the Wilcoxon signed-rank 
test for paired analysis. Health data (exhaled CO and NO, cell counts, and ELISAs) were 
also compared for statistical significance using the Wilcoxon signed-rank test. Spirometry 
data were normally distributed; therefore a paired t test was used for statistical analysis. Data 
were analyzed using GraphPad Prism version 6.00 for Windows (GraphPad Software, La 
Jolla California USA, www.graphpad.com). Statistical differences were measured for post-
diesel or post-B75 compared to baseline values and also post-diesel compared to post-B75 
values. For all analysis, statistical significance was taken as a two-tailed p-value of p<0.05. 




Characteristics of the 48 study participants, predominantly UA students, are summarized in 
Table 1. The average age was 25.7 years, approximately one third of the subjects were 
female, and three quarters were non-Hispanic white.
Diesel and B75 emission composition
rDPM sampling performed during mucking demonstrated a median of 336.40 μg/m3 for 
diesel exposures and 267.80 μg/m3 for B75 exposures, a 20% reduction (Table 2). There 
were no statistical differences between the fuel types when comparing acetaldehyde, 
formaldehyde, or NO levels. Nitrogen dioxide (NO2) and CO were significantly reduced in 
B75 compared to diesel exposures.
Lung function and exhaled CO and NO
At baseline 45 (94%) of the 48 subjects met the ATS standard for the top two FEV1 and 
FVC measurements being within 0.150L. Post-exposure, 43 (90%) of the 48 subjects using 
diesel fuel and 39 (81%) of the 48 subjects using biodiesel met the ATS standards. Among 
all subjects, FEV1 was significantly reduced following both diesel and B75 exposures 
compared to baseline (Table 3). Post-diesel FEV1 was also significantly lower than post-
B75 FEV1. FVC was only significantly reduced following diesel exposure. Additionally, 
post-diesel FVC was significantly reduced compared to post-B75. FEV1/FVC was 
significantly reduced after both diesel and B75 exposures. Both %COHb and FENO 
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significantly increased in subjects following both exposures (Table 4). There were no 
significant differences in the median levels of post-diesel %COHb, or FENO compared to 
post-B75.
Lung inflammatory cell infiltration
Sputum total white blood cell (WBC), neutrophil, and macrophage counts increased 
following emission exposures to both fuels and lymphocytes increased following diesel, but 
not B75 exposures (Table 5). When comparing post-diesel to post-B75 cell counts, there 
were no significant differences in any cell type.
Sputum and plasma inflammatory mediators
Sputum and plasma fluid-phase mediators selected a priori (IL-6, IL-8, MMP-9, MPO, and 
ET-1), increased from baseline following both exposures (Table 6). P-selectin decreased in 
the plasma following both exposures. There were no significant differences found in these 
levels when comparing post-diesel to post-B75. Sputum levels of each analyte, not adjusted 
for total protein, are included in Supplemental Table S1.
Novel biomarker discovery
Following proteomic analysis, a total of 848 sputum and 407 plasma proteins were 
identified. Using label-free spectral counting for relative quantitation, 42 and 32 candidate 
protein markers in the sputum and plasma, respectively, were identified that met the 
previously defined criteria (see Supplemental Material Methods and Supplemental Tables 
S2 and S3). Two sputum (MMP-8 and GRO-α) and one plasma (TN-C) candidate markers 
were further validated in all samples using ELISA (Table 6). Sputum MMP-8 significantly 
increased following both exposures. Sputum GRO-α was only significantly elevated in post-
B75 exposures, although there were no significant differences when comparing post-diesel 
to post-B75 levels. Plasma TN-C was significantly increased following diesel exposure, and, 
albeit not quite significantly, in the post-B75 exposures. There were no significant 
differences in post-diesel and post-B75 TN-C levels.
Urinary 8-OHdG
8-OHdG levels normalized to creatinine (ng 8-OHdG/mg creatinine) or specific gravity (SG) 
did not significantly increase or decrease from baseline following exposures to diesel or 
B75. There were no significant changes in 8-OHdG when comparing post-diesel and post-
B75 levels (Table 7).
Additional analyses
A sub analysis limited to subjects without any reported medical conditions or medication use 
(n=42) had similar outcomes to the analyses using all subjects, with the following 
exceptions. Sputum IL-8 increased significantly higher post-B75 compared to post-diesel 
exposures (p=0.041, median values 6.7 and 5.5 pg/μg, respectively). Plasma ET-1 lost 
statistical significance comparing baseline and post-B75 (p=0.093, median values 1.4 and 
1.6 pg/ml, respectively) but remained significant when comparing baseline to post-diesel 
(p=0.028, median values 1.4 and 1.5 pg/ml, respectively). When normalizing urinary 8-
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OHdG to specific gravity, the level decreased significantly following diesel exposures 
compared to baseline levels (p=0.045, median values 9.0 and 11.1 ng, respectively).
Discussion
In the current study, switching to B75 from diesel fuel led to a 20% reduction in rDPM 
exposure. This was consistent with previous reports demonstrating a reduction in DPM 
using biodiesel blends (6, 8, 17), although at least one study reported no difference in DPM 
(18). The mixed results can likely be attributed to the fuel blend, engine operating 
conditions, and pollution control devices (7, 19). The current study did not find significant 
increases in formaldehyde when switching from diesel to a biodiesel blend which is 
inconsistent with a previous report (18); however, CO levels were reduced significantly, 
which has been reported (20). Additionally, there were no statistical differences in 
acetaldehyde or oxides of nitrogen (sum of NO and NO2) in the current study when 
switching to a biodiesel blend from diesel, consistent with what has been previously 
reported (18, 20).
The respirable particulate concentrations reported in the current study are at the high end of 
reported ambient exposures, including those found most commonly in occupational settings 
(13, 21). However, the particulate concentrations are in the maximum range of those 
reported for highly polluted cities, such as Bejing (21, 22). At these elevated exposure 
concentrations, significant reductions in lung function as well as increases in both 
respiratory and systemic inflammation were observed. The marked inflammation is a likely 
pathway for lung cancer, other adverse respiratory effects, and cardiovascular disease; all of 
which are known sequelae of chronic DPM exposure (1–4, 23). The increased concentration 
seen post-exposure for most of the inflammatory biomarkers did not differ significantly 
between the two fuels, despite the 20% reduction in rDPM observed with B75 use. These 
findings bring into question the assumption that reductions in DPM concentrations from the 
use of alternative fuels will necessarily lead to decreased chronic toxicity.
Lung function was one of the health endpoints for which a significant difference was found 
comparing post-diesel and post-B75 values. Although acute changes in spirometry are not 
typically reported in studies where subjects are exposed to diluted diesel exhaust using 
controlled exposure chambers (24–27), at least one previous study demonstrated exposure to 
diesel exhaust decreased peak expiratory flow (28). In general, previous studies had a lower 
number of subjects, different exposure durations and environments, and lower particulate 
concentrations, all of which are plausible reasons for the observed variability.
Exhaled CO (expressed as %COHb) increased to a small extent with exposure to emissions 
from both fuel types. Percent COHb data were missing for 15 subjects due to equipment 
malfunction. Comparing subjects with and without full %COHb measurements, gender, but 
not age or ethnicity, varied significantly between the two groups. It is possible that the 15 
missing values in the study could have had a small effect on the %COHb levels that were 
reported, but given the relatively minor increase with both fuel types, the effect of the 
missing data is not likely to be biologically important.
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Additionally, this study revealed that FENO, a marker of airway inflammation, increased 
significantly and to the same levels following emission exposures to both fuel-types, 
comparable with previous findings of FENO increasing following acute diesel exhaust 
exposures (24). FENO has also been shown to increase in asthmatic children from urban air 
pollution with positive correlations between the concentration of pollutants and the level of 
airway inflammation (29).
Diesel exhaust has been shown to increase inflammatory cell recruitment into the airways 
(25–27). These increases were typically measured 6–24 hours after initial diesel exposure, 
consistent with the approximately 8.5 hours after initial exposure to each fuel-type in this 
study. We observed similar increases in cell counts for neutrophils and macrophages 
following exposures to diesel and B75, although lymphocytes increased significantly 
following diesel, but not B75, exposures.
IL-6 and IL-8 are cytokines released by several cell types during an inflammatory response. 
The mRNA and protein expression of these two cytokines has been studied in vitro and in 
vivo (30–32) to measure the level of inflammation from exposures to diesel particulates and 
air pollution. Additionally, the increased airway release of IL-6 and IL-8 has been seen in 
human studies analyzing acute diesel exhaust exposures (28, 33, 34). Accordingly, we 
observed a significant increased release of both IL-6 and IL-8 in the sputum following diesel 
and B75 exposures. The extent of IL-6 release was similar for both fuel-types and IL-8 was 
slightly (but not significantly) higher for B75 exposures.
MMP-8 (secreted exclusively by neutrophils) and MMP-9 (secreted by many cell types) are 
involved in the remodeling of the extracellular matrix under normal physiological processes 
and also inflammation and metastasis. MMP-8 has been used as a biomarker of 
inflammation and cardiovascular disease (35). However, the acute elevation of MMP-8 
observed in response to diesel and B75 emission exposures is a novel finding. The increased 
levels measured in this study are likely related to the neutrophil infiltration observed in the 
lung. Induced sputum MMP-9 levels have been shown to be correlated with lung function 
and airway inflammation, displaying an inverse relationship with FEV1 and a significant 
correlation with total white cells, neutrophils and IL-8 (36). This suggests MMP-9 may be a 
promising marker of airway effect for DPM exposure.
MPO is an enzyme that has potent pro-oxidative and pro-inflammatory properties and is 
typically released from activated neutrophils; accordingly its levels have been used as a 
marker of inflammation and cardiovascular disease. In a recent study analyzing mouse lung 
and liver toxicity following equivalent doses of diesel or biodiesel emissions, MPO levels 
displayed a greater dose-related increase following biodiesel, compared to diesel, emission 
exposures (37). In the current study, MPO levels in the sputum increased to similar levels 
following diesel and B75 exposures.
GRO-α preferentially chemoattracts and activates neutrophils. This protein is inducible by 
tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1). Previous human studies have 
shown a non-significant increase of GRO-α following acute diesel exhaust exposures (33, 
38). In the current study, GRO-α was identified in the sputum via proteomic strategies as a 
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candidate biomarker being elevated following B75 exposures. When ELISA analysis was 
performed on all sputum samples, GRO-α was significantly elevated following only B75 
emission exposures, also a novel finding.
ET-1 is an endothelin-derived vasoconstrictor peptide that is an inflammatory mediator. 
Increased levels of ET-1 have been reported in cardiovascular and inflammatory lung 
diseases (39, 40). A previous human study showed increases in plasma ET-1 levels after 
acute exposures to diesel exhaust (41), suggesting an early endothelial response and 
vasoconstriction. The current study demonstrated similar significant increases in plasma 
ET-1 levels after diesel and B75 exposures, suggesting that the level of vascular dysfunction 
is similar from exposures to both fuel-types.
P-selectin is responsible for mediating the rolling of leukocytes over vascular surfaces 
during early stages of inflammation. In chamber studies of acute human exposure to filtered 
diesel exhaust (300 μg/m3 for 1 hour), plasma P-selectin levels were not significantly altered 
at 2 or 6 hours post-exposure (42), but increased significantly at 24 hours post-exposure 
(43). These results are inconsistent with the current study findings, where P-selectin 
decreased 5.5 hours after initial exposure to both fuel-types. Different exposure 
environments, engine, and engine operating conditions may be plausible explanations for the 
inconsistencies between the studies. It has also been shown that exercise training can reduce 
plasma inflammatory mediators such as P-selectin (44–46). While participation in the 
current study required moderate physical exertion during mucking, it is unclear if this level 
of exertion caused the decrease in plasma P-selectin.
TN-C is an extracellular matrix protein important in tissue injury and repair, but also 
disease-states such as chronic inflammation and tumorigenesis. Additionally, TN-C is 
capable of inducing pro-inflammatory cytokines (47). High circulating concentrations of 
plasma TN-C have been reported in association with mortality and cardiovascular disease in 
chronic kidney patients (48). In the current study, TN-C was identified in the plasma via 
proteomic strategies as a novel biomarker candidate that increased following exposures to 
diesel and B75 emissions. These increased TN-C plasma levels may be due to lung and/or 
endothelial damage.
The current study is the first human study to use proteomic strategies to reveal novel 
biomarkers of emission exposures to both diesel and B75. The candidate biomarkers in the 
sputum and plasma (MMP-8, GRO-α, and TN-C) were validated by ELISA. The most 
comparable previous study was performed on rat bronchoalveolar lavage fluid (BALF) after 
different exposure concentrations and durations to diesel exhaust particles (DEP) (49); this 
study revealed a total of 65 proteins using LC/MS analysis on whole and weak cation 
exchange (WCX) extracted BALF, with two distinct proteins (anaphylatoxin C3a and 
calgranulin A) appearing post-exposure at all DEP doses.
The accumulation of rDPM in the lung leads to a large inflammatory response, as seen in the 
current study and many others. It is well established that inflammatory events lead to an 
increase in reactive oxygen species (ROS) that can damage proteins and DNA. A classic 
biomarker of oxidative stress to DNA is urinary 8-OHdG (50). 8-OHdG is an oxidized DNA 
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nucleoside that is eliminated in the urine after excision by DNA repair enzymes. Increased 
levels of 8-OHdG have been measured following a minimum of three month’s occupational 
exposures to ambient PM2.5 in Taiwanese traffic conductors (51). In the current study, urine 
8-OHdG did not increase significantly 8–10 hours following initial diesel or B75 exhaust 
exposure.
The current study has several important limitations. It measured health effects reflecting the 
use of diesel and an alternative (B75) fuel while operating the same vehicle, producing 
different rDPM concentrations, and therefore did not compare the toxicity of the same 
concentration of rDPM from each fuel type. Multiple health parameters were assessed, but 
each at a single time point following a single 200-minute exposure. More prolonged 
exposure periods, or the measurements of health parameters at other time points, would 
potentially produce different results. Additionally, only one blend of biodiesel (B75) and 
type (soy methyl ester) was evaluated in this study, while there are a variety of biodiesel 
blends in use. Also, the use of different pollution control devices and engine operating 
conditions will affect the overall toxicity of the exhaust produced, so it is important not to 
generalize the study findings beyond the use of diesel engines with only a DOC. A cross-
over study design was employed, rather than randomizing by fuel type for each day of 
testing, which may have introduced bias. Lastly, this study concentrated on markedly 
elevated exposure concentrations, and the effects of lower concentrations would be expected 
to result in less marked health effects, which could potentially vary to a greater or lesser 
degree by fuel type.
Conclusion
In the current study we evaluated multiple health parameters following acute exposure to 
diesel and B75 emissions. Although lung function was affected to a greater degree by diesel 
emissions, many biomarkers of effect including measures of inflammation and oxidative 
stress were similar when comparing the two fuel-types, despite the 20% reduction in rDPM 
achieved by the use of B75. Additional studies are needed to evaluate the potential 
differential health effects from emissions of these fuels at both lower concentrations and for 
more chronic exposure periods, as well as for a larger selection of biodiesel fuel sources, 
blend concentrations, and pollution control devices. The present study highlights the need to 
further evaluate the health effects associated with alternative fuels, and not assume that 
reduction in rDPM alone will lead to reduced health effects.
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Mean age (yr) (min-max) 25.7 (19–53)
Sex
 Male 31 (64.6 %)
 Female 17 (35.4 %)
Race
 White, non-Hispanic 36 (75.0 %)
 Hispanic 5 (10.4 %)
 African 4 (8.3 %)
 Asian 2 (4.2 %)
 Other 1 (2.1 %)
Mean height (cm), (SD) 174.5 (9.2)
Mean weight (kg), (SD) 76.9 (17.2)
Mean body mass index (kg/m2), (SD) 25.2 (5.2)
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Table 2
Analyte TWA8 exposure concentrations.
Analyte Diesel B75 p-value
rDPM (μg/m3)a 336.40 (226.13–432.00) 267.80 (159.10–378.30) 0.0780
Acetaldehyde (ppm)b 0.04 (0.03–0.04) 0.03 (0.02–0.04) 0.1922
Formaldehyde (ppm)b 0.10 (0.07–0.12) 0.10 (0.08–0.12) 0.7648
NO (ppm)c 10.27 (7.45–12.03) 12.54 (6.32–15.15) 0.1647
NO2 (ppm)c 1.58 (1.16–1.89) 1.19 (0.91–1.54)* 0.0423
CO (ppm)c 13.39 (7.45–19.73) 8.87 (6.88–15.55)* 0.0182
rDPM, respirable diesel particulate matter; NO, nitric oxide; NO2, nitrogen dioxide; and CO, carbon monoxide.
Data are presented as median (IQR). The differences in n resulted from equipment malfunction.
*
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Table 3
Changes in lung function (n = 48).
Parameter Baseline Post-diesel Post-B75 p-valuea
FEV1 (L) 4.05 ± 0.65 3.85 ± 0.64*** 3.96 ± 0.66*** 0.0051
% Predicted FEV1 98.46 ± 11.02 93.65 ± 10.59*** 96.10 ± 11.14*** 0.0047
FVC (L) 4.86 ± 0.83 4.74 ± 0.81** 4.83 ± 0.83 0.0263
% Predicted FVC 99.17 ± 11.42 96.67 ± 9.76** 98.48 ± 10.88 0.0148
FEV1/FVC (%) 83.77 ± 5.60 81.60 ± 6.16*** 82.32 ± 6.10** 0.2006




p<0.001 compared with baseline using paired t test.
a
paired t test comparing post-diesel with post-B75.
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Table 5
Sputum total and differential cell counts (n = 48).
Cell (106/ml) Baseline Post-diesel Post-B75 p-valuea
Total WBC 1.06 (0.50–1.78) 2.59 (0.97–4.91)*** 2.59 (1.46–4.53)*** 0.6729
Neutrophil 0.40 (0.15–0.65) 1.31 (0.45–2.63)*** 1.32 (0.72–2.30)*** 0.6731
Macrophages 0.58 (0.26–1.16) 1.12 (0.47–2.16)*** 1.15 (0.57–2.11)*** 0.6880
Lymphocytes 0.01 (0.00–0.02) 0.02 (0.00–0.04)* 0.01 (0.00–0.03) 0.1993
WBC, white blood cells.




p<0.001 compared with baseline by Wilcoxon signed-rank test.
a
Comparing post-diesel with post-B75 using Wilcoxon signed-rank test.
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Table 6
Sputum and plasma inflammatory mediators (n = 48).
Analyte Baseline Post-diesel Post-B75 p-valuea
Sputum
IL-6 (pg/μg) 0.1 (0.0–0.1) 0.3 (0.1–0.7)*** 0.3 (0.1–0.8)*** 0.8350
IL-8 (pg/μg) 3.7 (2.9–6.3) 5.8 (3.4–9.7)*** 7.5 (4.3–10.5)*** 0.0840
MMP-9 (ng/μg) 0.7 (0.4–1.2) 1.7 (0.9–3.4)*** 1.8 (1.2–2.9)*** 0.9878
MPO (ng/μg) 0.8 (0.5–1.5) 1.7 (0.6–3.4)*** 1.6 (0.9–2.5)*** 0.6219
MMP-8† (ng/μg) 0.5 (0.3–0.8) 1.2 (0.6–2.2)*** 1.1 (0.8–2.1)*** 0.7030
GRO-α† (pg/μg) 18.3 (9.4–45.8) 19.7 (9.2–48.3) 23.8 (13.4–76.3)** 0.0859
Plasma
ET-1 (pg/ml) 1.5 (1.3–1.8) 1.6 (1.3–2.2)** 1.6 (1.4–1.9)* 0.6350
P-selectin (ng/ml) 39.5 (32.4–49.7) 33.6 (29.2–40.4)*** 32.4 (25.7–40.5)*** 0.4301
TN-C† (ng/ml) 64.3 (45.0–82.7) 67.6 (46.6–94.6)** 71.8 (50.4–88.3) 0.3356
IL-6, interleukin-6; IL-8, interleukin-8; MMP-8, matrix metalloproteinase-8; MMP-9, matrix metalloproteinase-9; MPO, myeloperoxidase; GRO-
α, growth-regulated alpha protein; ET-1, endothelin-1; TN-C, tenascin-C.






p<0.001 for comparison with baseline using Wilcoxon signed-rank test.
†
indicates protein was identified as a candidate biomarker using proteomic strategies.
a
Comparing post-diesel with post-B75 using Wilcoxon signed-rank test.
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